Pluristem Therapeutics Inc.
12.10.2017 | TASE
A cross-office team of lawyers from Tel Aviv, New York and Boston represented Pluristem Therapeutics in a public offering worth $15 million on the Tel Aviv Stock Exchange.
Pluristem was able to raise money on the Tel Aviv Stock Exchange by selling shares listed on Nasdaq. Oded Har-Even, Reut Alfiah, Eran Ben-Dor and Howard Berkenblit led the transaction.